Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables

被引:63
作者
Donadieu, J
Auclerc, MF
Baruchel, A
Leblanc, T
Landman-Parker, J
Perel, Y
Michel, G
Cornu, G
Bordigoni, P
Sommelet, D
Leverger, G
Hill, C
Schaison, G
机构
[1] Inst Gustave Roussy, Dept Biostat & Epidemiol, F-94805 Villejuif, France
[2] Hop St Louis, Serv Hematol Pediat, Paris, France
[3] Hop Trousseau, Serv Hematooncol Pediat, F-75571 Paris, France
[4] Hop Pellegrin, Serv Hematooncol Pediat, F-33076 Bordeaux, France
[5] Hop Enfants La Timone, Serv Hematol Pediat, Marseille, France
[6] Fac Med Louvain, Dept Hematol Infantile, Brussels, Belgium
[7] Hop Brabois, Serv Med Infantile 2, Nancy, France
关键词
acute lymphoblastic leukaemia; childhood; prognostic factors; proportion of explained variation;
D O I
10.1046/j.1365-2141.1998.00818.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We determined the proportion of survival variability explained by the usual prognostic factors in childhood acute lymphoblastic leukaemia (ALL) during a prognostic study of 1552 patients enrolled in three consecutive Fralle group protocols (Fralle 83, Fralle 87 and Fralle 89), The event-free survival rates at 5 years were 54.8% (SD 1.9), 43.1% (SD 2.7) and 55.6% (SD 2.2), respectively. In the univariate analysis the following variables were predictive of poor outcome: male gender, elevated leucocytosis (> 50 x 10(9)/l), circulating blastosis, haemoglobin >12 g/dl, platelet count <100 x 10(9)/l, age under 1 year or over 9 years, enlarged mediastinum, nodes, spleen and liver, T phenotype, absence of CD10(+) cells; testicular and meningeal involvement, poor response to induction therapy (CCSG M3), and LDH >400 U/l. Among the cytogenetic features, hyperdiploidy had a protective effect, whereas hypodiploidy, translocation and other structural abnormalities had a negative influence, particularly in cases of t(9;22) or t(4;11). Multivariate analysis summarized the prognostic information in terms of four variables: age, gender, leucocytosis and cytogenetic features. Missing data had little influence on the results. However, despite their significance in the multivariate analysis, these four variables each had very low predictive power (1.1% for gender, 2.0% for age, 3.5% for leucocytosis, and 1.6% for cytogenetic features). Thus, the most significant prognostic factors in childhood ALL each explain no more than 4% of the variability in prognosis, This may explain the disappointing practical value of these factors and underlines the need for prognostic tools in childhood ALL.
引用
收藏
页码:729 / 739
页数:11
相关论文
共 63 条
  • [1] AHNERENNASSIH E, 1995, ANN HEMATOL, V70, P131
  • [2] ARICO M, 1995, CANCER, V75, P1684, DOI 10.1002/1097-0142(19950401)75:7<1684::AID-CNCR2820750720>3.0.CO
  • [3] 2-2
  • [4] DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE-LEUKEMIA - METHODOLOGIC ADVANCES AND CLINICAL-SIGNIFICANCE
    CAMPANA, D
    PUI, CH
    [J]. BLOOD, 1995, 85 (06) : 1416 - 1434
  • [5] INTENSIFICATION OF TREATMENT AND SURVIVAL IN ALL CHILDREN WITH LYMPHOBLASTIC-LEUKEMIA - RESULTS OF UK MEDICAL-RESEARCH-COUNCIL TRIAL UKALL-X
    CHESSELLS, JM
    BAILEY, C
    RICHARDS, SM
    EDEN, OB
    BARBOR, PRH
    BARRETT, A
    BARTON, C
    BROADBENT, V
    DEMPSEY, SI
    DURRANT, J
    EMERSON, P
    EVANS, DIK
    FENNELLY, JJ
    GALTON, DAG
    GIBSON, B
    GRAY, R
    HANN, IM
    HARDISTY, RM
    HILL, FGH
    KERNAHAN, J
    KING, DJ
    LILLEYMAN, JS
    MANN, J
    MARTIN, J
    MCELWAIN, TJ
    MELLOR, ST
    JONES, PHM
    OAKHILL, A
    PETO, J
    RADFORD, M
    REES, JKH
    STEVENS, RF
    SUMMERFIELD, GP
    THOMPSON, EN
    [J]. LANCET, 1995, 345 (8943) : 143 - 148
  • [6] Collet D., 1994, MODELLING SURVIVAL D, V1st
  • [7] CORTES JE, 1995, CANCER-AM CANCER SOC, V76, P2393, DOI 10.1002/1097-0142(19951215)76:12<2393::AID-CNCR2820761203>3.0.CO
  • [8] 2-P
  • [9] CLINICAL AND BIOLOGIC FEATURES PREDICT POOR PROGNOSIS IN ACUTE LYMPHOID LEUKEMIAS IN CHILDREN AND ADOLESCENTS - A PEDIATRIC ONCOLOGY GROUP REVIEW
    CRIST, W
    BOYETT, J
    PULLEN, J
    VANEYS, J
    VIETTI, T
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1986, 14 (03): : 135 - 139
  • [10] CRIST W, 1990, BLOOD, V76, P489